Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing Burberry Shares Climb on Report of Potential Moncler Takeover Interest Bitcoin Dips Below 76000 as Iran Tensions and ETF Outflows Weigh on Sentiment Amazon Sells AI Shopping Technology to Retailers Signs Kate Spade Microsoft in Talks to Supply Custom AI Chips to Anthropic Deepening Partnership After 5 Billion Investment Europe Risks AI Dependency Trap as US and Asia Dominate Supply Chains Warns Report FIP Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares ENB Q1 2026 Earnings EPS Beat by 306 Despite Broader Market Headwinds UUU Q4 2024 Earnings Loss per Share of 021 Amid Mixed Reporting CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment PENG Q1 2026 Earnings Strong EPS Beat Drives 9 Surge WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates MainStreet Bancshares MNSBP Holds Steady at 2504 Analyzing Key Support and Resistance Levels BG Foods Inc BGS Rallies 196 as Volume Picks Up Testing Key Resistance Zone CF Financial Corporation CFFI Faces Modest Pullback Support and Resistance Levels in Focus Leishen Energy Holding LSE Consolidates Near Resistance After Modest Gain Golden Entertainment GDEN Holds Steady at 2855 as Support and Resistance Levels Come into Focus SpaceX Successfully Launches Starship on Second Attempt Advancing Private Space Ambitions FSBC Q1 2026 Earnings EPS Beats Expectations Despite Flat Stock Reaction SiteOne Landscape Supply SITE Declines 185 as Stock Nears Key Support Level LPL Financial LPLA Slips Slightly as Traders Eye Key Support and Resistance Levels Indivior INDV Holds Steady with Slight Gain as Stock Tests Resistance Near 40 Perimeter Solutions SA PRM Edges Higher on Modest Gains as Shares Test Key Moving Averages Smart Logistics Global Limited SLGB Surges 838 Whats Driving the Move Kochav Defense Acquisition Corp KCHV Holds Steady Near 1034 Amid SPAC Stability Onity Group Inc ONIT Faces Modest Decline Tests Key Support Levels Ernexa Therapeutics ERNA Slides 25 as Weakness Persists Near Support Levels